Accès ouvert
2026
article
OpenAlex
Nalan Gülşen Ünal, Oğuz Kağan Bakkaloğlu, Taylan Kav, Tuğçe Eşkazan et autres
BACKGROUND: Acute severe active ulcerative colitis (ASUC) often requires rescue therapy when standard medical treatment fails. Data on the use of upadacitinib (UPA) as a rescue option after failure of steroids and infliximab (IFX) and on the long-term outcomes of UPA treatment …
tr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Xinyi Xu, Y Shi, Frank Tacke, Vincent Wai‐Sun Wong et autres
BACKGROUND & AIMS: Hepatology is experiencing major shifts in disease etiologies and is raising demand for multidisciplinary care. However, a globally harmonized framework defining core training content remains lacking. We aimed to develop a globally informed expert consensus framework for the content …
cn, de, hk, gb, ca, es, us, fr, kr, it, tr, mm, Ouganda, am, bd, pk, id, se, fi, jp, th, ph, vn, Afrique du Sud, lk, az, sg, mx, nz, sa, lb, Algérie, br, ae, nl, Soudan, om, Ghana, Égypte, ch, ro, ie, my, pt, at, in, gr, be, au
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Melek Balamir, Bartu Avci, Elara Coşan, Sinan Tanyolaç et autres
Background/Objectives: Exocrine pancreatic insufficiency (EPI) is increasingly recognized in patients with diabetes; however, its clinical correlates remain poorly defined. This study aimed to determine the prevalence and clinical characteristics of EPI in patients with type 1 (T1DM) and type 2 diabetes mellitus …
tr
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Besim F. Agˇargün, Sezen Genc Ulucecen, Gizem Dagci, Mehmet A. Yagli et autres
2026
conference-abstract
OpenAlex
Besim F. Agˇargün, Sezen Genc Ulucecen, Gizem Dagci, Mehmet A. Yagli et autres
2026
conference-abstract
OpenAlex
Soner Altın, Sait Kayalı, Ahmet Oğuz Çelik, Gamze Kemeç et autres
Accès ouvert
2026
article
OpenAlex
Zülal İstemihan, Mehmet Akif Yağlı, Pelin Telli, Gizem Dağcı et autres
Objective: This study aimed to investigate the features of eight patients diagnosed with primary gastrointestinal system lymphoma.Materials and Methods: The features of patients diagnosed with primary gastrointestinal system lymphoma between 2021 and 2024 at the İstanbul Faculty of Medicine, Department of Internal …
tr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Sezen Genç Uluçeçen, Kadir Tezcan, Ali Cem Hacialioglu, Gizem Dağcı et autres
Abstract Introduction Chronic exogenous exposures related to perianal fistula care may lead to systemic effects in patients with Crohn’s disease and require a multisystemic evaluation. In this case, we aimed to raise awareness by presenting a rarely encountered treatment-related complication in a …
tr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Tuğçe Eşkazan, Oğuz Kağan Bakkaloğlu, Murat Törüner, Haluk Tarık Kani et autres
Background: Azathioprine (AZA)-associated acute pancreatitis (AP) and gastrointestinal intolerance (GI-INT) are major causes of drug discontinuation in inflammatory bowel disease (IBD). This study compared HLA alleles, demographics, and clinical variables between AZA-AP and AZA-GI-INT. Methods: Data from five IBD centers included control …
tr
(code pays fourni par la source)
2025
article
OpenAlex
Filiz Akyüz, Besim Fazıl Ağargün, Özlen Atuğ, Tuğçe Eşkazan et autres
BACKGROUND: The incidence of inflammatory bowel disease (IBD) is rising in newly industrialized nations, yet nationally representative data from Türkiye are limited. We characterized recent epidemiologic trends, clinical features, and geographic distribution of newly diagnosed IBD across Türkiye. METHODS: This retrospective multicenter …
tr, jp
(code pays fourni par la source)
2025
article
OpenAlex
Nikos Viazis, Murat Törüner, Vasilios Papastergiou, Konstantinos Mousourakis et autres
OBJECTIVES: To identify the rate and predictors of successful antitumor necrosis factor (TNF) dose deescalation in patients with inflammatory bowel disease (IBD). METHODS: This multicenter retrospective cohort study collected data from consecutive IBD patients followed at referral centers in Greece and Turkey, …
gr, tr, us, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Serhat Bor, Hasan Özen, İsmail Hakkı Kalkan, Filiz Akyüz et autres
Antispasmodics are commonly used to treat irritable bowel syndrome (IBS) symptoms. They are generally regarded as safe.However, some have been found to be ineffective or not cost-effective. Marked discrepancies in the availability and formulation of antispasmodic agents across countries—ranging from the limitation …
tr, us
(code pays fourni par la source)